1h Free Analyst Time
The oncology market in india is forecasted to grow by USD 1.49 billion during 2023-2028, accelerating at a CAGR of 17.43% during the forecast period. The report on the oncology market in india provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased prevalence of cancer, growing investment for cost-cutting in drug discovery and development, and increasing demand for precision medicine.
The oncology market in india is segmented as below:
By Type
- Cancer treatment
- Cancer diagnostics
By End-user
- Hospitals
- Diagnostic laboratories
- Diagnostic imaging centers
- Others
By Geographical Landscape
- Asia
The report on the oncology market in india covers the following areas:
- Oncology market in india sizing
- Oncology market in india forecast
- Oncology market in india industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the oncology market in India: 3M Co., Abbott Laboratories, Alkem Laboratories Ltd., AstraZeneca PLC, Baxter International Inc., Bristol Myers Squibb Co., Cipla Inc., F. Hoffmann La Roche Ltd., GE Healthcare Technologies Inc., Glenmark Pharmaceuticals Ltd., Lupin Ltd., Medtronic PLC, Merck and Co. Inc., Natco Pharma Ltd., Novartis AG, Poly Medicure Ltd., Siemens Healthineers AG, Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rise in research and development for developing diagnostic devices."
According to the report, one of the major drivers for this market is the increased prevalence of cancer.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M Co.
- Abbott Laboratories
- Alkem Laboratories Ltd.
- AstraZeneca Plc
- Baxter International Inc.
- Bristol Myers Squibb Co.
- Cipla Inc.
- F. Hoffmann La Roche Ltd.
- GE Healthcare Technologies Inc.
- Glenmark Pharmaceuticals Ltd.
- Lupin Ltd.
- Medtronic PLC
- Merck and Co. Inc.
- Natco Pharma Ltd.
- Novartis AG
- Poly Medicure Ltd.
- Siemens Healthineers AG
- Sun Pharmaceutical Industries Ltd.
- Torrent Pharmaceuticals Ltd.
- Zydus Lifesciences Ltd.
